Roopa Industries Reports Sales Growth Amid Financial Health Concerns and Market Sentiment Shift

Mar 12 2025 08:03 AM IST
share
Share Via
Roopa Industries, a microcap in the Pharmaceuticals & Drugs sector, recently adjusted its evaluation amid mixed performance indicators. In Q3 FY24-25, the company reported a significant rise in net sales and achieved its highest profit after tax. However, challenges include a low return on capital employed and a high debt to EBITDA ratio.
Roopa Industries, a microcap player in the Pharmaceuticals & Drugs sector, has recently undergone an adjustment in evaluation, reflecting the company's current market dynamics. The latest assessment highlights a mix of performance indicators that paint a complex picture of its financial health.

In the most recent quarter, Q3 FY24-25, Roopa Industries reported a notable increase in net sales, reaching Rs 30.73 crore, which represents a growth of 21.2% compared to the previous four-quarter average. Additionally, the company achieved its highest profit after tax (PAT) of Rs 0.76 crore and an earnings per share (EPS) of Rs 0.97, indicating a positive trend in profitability.

However, the evaluation also points to underlying challenges. The company exhibits a relatively low return on capital employed (ROCE) of 5.09%, suggesting limitations in long-term fundamental strength. Furthermore, a high debt to EBITDA ratio of 7.12 times raises concerns about its ability to service debt effectively.

Despite these challenges, Roopa Industries has shown resilience with positive results over the last three consecutive quarters. The stock's technical indicators have shifted into a bearish range, reflecting broader market sentiments.

For those interested in further insights, Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News